Skip to main content
logo
Caltagirone SpA (CALT)
Sep 20, 2024 - CALT was voluntarily delisted
40.00
-0.04 (-0.10%)
Inactive · Last trade price on Sep 20, 2024

CALT Revenue

In the year 2024, Calliditas Therapeutics AB had annual revenue of 2.11B EUR with 8.54% growth. Calliditas Therapeutics AB had revenue of 1.13B in the half year ending December 31, 2024, with 11.75% growth.

Revenue (ttm)
2.11B EUR
Revenue Growth
+8.54%
P/S Ratio
0.45
Revenue / Employee
537,654 EUR
Employees
3,925
Market Cap
988.36M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.11B165.97M8.54%
Dec 31, 20231.94B3.73M0.19%
Dec 31, 20221.94B364.11M23.10%
Dec 31, 20211.58B141.77M9.88%
Dec 31, 20201.43B-22.01M-1.51%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CALT News

More News